Log in or Sign up for Free to view tailored content for your specialty!
Hormone Therapy News
Menopausal hormone therapy may protect against adhesive capsulitis
Women who did not receive menopausal hormone therapy had greater odds of developing adhesive capsulitis compared with those on HT, according to preliminary study results presented at the North American Menopause Society annual meeting.
Benefits of gender-affirming HT outweigh risks for most transgender women
The benefits of gender-affirming hormone therapy outweigh the risks for transgender women of all ages as well as those with comorbidities, according to a speaker at the 2022 North American Menopause Society annual meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Fewer, less severe vasomotor symptoms reported by postmenopausal women using estetrol
The estrogen estetrol was associated with decreased frequency and severity of vasomotor symptoms for postmenopausal women, study findings presented at the NAMS Annual Meeting showed.
Certain contraceptives may increase risk for thrombotic events in women with obesity
Use of combined oral contraceptives in women with obesity may confer elevated CV risk in the form of venous and arterial thromboembolism, researchers reported.
Assess CVD risk when considering hormone therapy for menopause symptoms
RANCHO PALOS VERDES, Calif. — Menopausal hormone therapy can help alleviate severe vasomotor symptoms, but cardiologists should assess CV risk and consider several other factors when evaluating these patients, according to a speaker.
Burden of menopausal hot flashes increased during past 50 years
Women born in 1954 and 1966 were nearly twice as likely to experience daily hot flashes at age 50 years than women born in 1918 and 1930, regardless of obesity, smoking status, stress and hormonal therapy, according to study data.
Focus on CV risk, T Trials follows 20-year rise in testosterone use
During the past 2 decades, Endocrine Today has reported on the latest developments in testosterone therapy, including new formulations, debates over indications, and trials assessing risks and benefits for older men.
Metformin, testosterone therapies lower risk for certain hormone-related cancers in men
In a large cohort of men, pre‐diagnostic use of metformin and testosterone replacement therapy was associated with lower incidence of prostate and colorectal cancers, but not male breast cancer, according to research.
Top news from ENDO: hair care EDCs, cell phone-obesity link, AI thyroid diagnosis and more
The Healio and Endocrine Today editors have compiled the most read news from the Endocrine Society annual meeting in June.
Female patients with RA receiving exogenous sex hormones more likely to achieve remission
Female patients with rheumatoid arthritis are more likely to achieve remission when treated with exogenous sex hormones, particularly those who are perimenopausal and early postmenopausal, according to data published in Rheumatology.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read